insights_auto
Why is AMGN34 up 3,30%?
Dive Deeperchevron_right
AMGN34:BVMF
Amgen Inc. BDR
74,12 BRL
arrow_upward
+3,30%(+2,37) 1D
7-окт., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
73,64 BRL
High
74,20 BRL
Low
73,64 BRL
Mkt. cap
223,32 млд
Avg. vol.
412,00
Volume
63,00
52-wk high
83,06 BRL
52-wk low
47,76 BRL
Shares outstanding
540,63 млн
No. of employees
32 миң
Open
73,64 BRL
High
74,20 BRL
Low
73,64 BRL
Mkt. cap
223,32 млд
Avg. vol.
412,00
Volume
63,00
52-wk high
83,06 BRL
52-wk low
47,76 BRL
Shares outstanding
540,63 млн
No. of employees
32 миң
News stories
From web sources and news partners
MarketWatch
·
1 саат мурун
Amgen Inc. stock outperforms competitors on strong trading day
TradingKey
·
5 саат мурун
Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis
MarketBeat
·
6 саат мурун
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Truist Financial Analyst Says
Investing.com
·
7 саат мурун
Truist raises Amgen stock price target to $380 on pipeline growth
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 миң
Founded1980
HeadquartersТаусанд Окс, Калифорния, Америка Кошмо Штаттары
Sector-
Websiteamgen.com